<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00975923</url>
  </required_header>
  <id_info>
    <org_study_id>VU050413</org_study_id>
    <secondary_id>AHRQ U18 HS015934</secondary_id>
    <nct_id>NCT00975923</nct_id>
  </id_info>
  <brief_title>Safe Critical Care: Testing Improvement Strategies</brief_title>
  <official_title>Safe Critical Care: Testing Improvement Strategies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      One group of hospitals participated in a collaborative approach for healthcare quality
      improvement while another group was provided only a tool kit. The investigators' objective
      was to determine if the Collaborative would perform better at preventing central
      line-associated bloodstream infections (CLABSI) and ventilator-associated pneumonias (VAP).
      Hospitals were randomized to the Tool Kit or Collaborative conditions. The investigators'
      study evaluated the effects on care processes and outcomes of a multi-institutional quality
      improvement initiative focused on preventing hospital associate infections. The
      investigators' hypothesis was that the strategies for implementing safe critical care
      practice will differ in level of achievement whereby the Collaborative group will perform
      better than the Tool Kit group. The outcome measure comprised clinical event rates and an
      index of safe practices that represent a bundling of key process measures related to
      evidence-based practices for preventing catheter-related blood-stream infections and
      ventilator-associated pneumonia in the intensive care unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Continuous quality improvement (CQI) methodologies provide a framework for initiating and
      sustaining improvements in complex systems.1 By definition, CQI engages frontline staff in
      iterative problem solving using plan-do-study-act cycles of learning, with decision-making
      based on real-time process measurements. The Institute for Healthcare Improvement (IHI) has
      sponsored Breakthrough Series (BTS) Collaboratives since 1996 to accelerate the uptake and
      impact of quality improvement. These collaboratives are typically guided by evidence-based
      clinical practice guidelines, incorporate change methodologies, and rely on clinical and
      process improvement subject matter experts. Organizations have been adopting the
      collaborative model, and there is a growing literature on its positive impact. This
      collaborative approach to healthcare improvement has appealing face validity but lacks
      definitive evidence of its effectiveness. A recent derivative of collaboratives has been
      deployment of tool kits for quality improvement. Intuition suggests that such tools kits may
      help to enable change, and, thus some agencies advocate the simpler approach of disseminating
      tool kits as a change strategy. We sought to compare the collaborative model with the tool
      kit model for improving care. Recommendations and guidelines for central line-associated
      bloodstream infection (CLABSI) and ventilator-associated pneumonia (VAP) prevention have not
      been implemented reliably, resulting in unnecessary ICU morbidity and mortality and fostering
      a national call for improvement. Our study evaluated the effects on care processes and
      outcomes of a multi-institutional quality improvement initiative focused on preventing CLABSI
      and VAP in the intensive care unit (ICU).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CLABSI and VAP Rates</measure>
    <time_frame>18 Months: 3-month baseline and quarterly post-intervention periods</time_frame>
    <description>Central line associated bloodstream infections(CLABSI) and ventilator associated pneumonias (VAP) using Centers for Disease Control and Prevention definitions as number of events per 1,000 device days, data collection and surveillance methods.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Access of Tools and Use of Quality Improvement Strategies</measure>
    <time_frame>18 months</time_frame>
    <description>Follow-up survey of ICU nurse and quality managers for all participating medical centers from Jan 2008 through April 2008 included questions about the implementation of process interventions: Access and use of clinical guidelines tools, access and use of quality improvement tools, and types of quality improvement implementation strategies.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">59</enrollment>
  <condition>Central Line-associated Bloodstream Infection (CLABSI)</condition>
  <condition>Ventilator Associated Pneumonia</condition>
  <arm_group>
    <arm_group_label>Collaborative Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Quality Improvement Virtual Learning Collaborative with Interactive Teleconferences and Tool Kit</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tool Kit Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tool Kit of Evidence-Based Guidelines, Education Seminars, and Aide for Quality Improvement Methods</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Collaborative Group</intervention_name>
    <description>In addition to the Tool Kit materials and web site support, facility leaders and managers in this group agreed to participate in a Collaborative to improve critical care. The Collaborative differed from the IHI BTS model in that teams did not come together for face-to-face educational and planning sessions but instead attended web seminars and teleconferences. Between these &quot;virtual&quot; learning sessions, teams implemented some of the suggested change ideas, measured the results of those changes, and reported back to the larger group. Teams were supported through monthly educational and troubleshooting conference calls, individual coaching by faculty members, and an e-mail listserver designed to stimulate interaction among teams.</description>
    <arm_group_label>Collaborative Group</arm_group_label>
    <other_name>Collaborative Breakthrough Groups</other_name>
    <other_name>Collaborative Quality Improvement Groups</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tool Kit</intervention_name>
    <description>Hospitals received a tool kit:evidence-based guidelines, CLABSI/VAP fact sheets, change ideas,quality improvement and teamwork methods, standardized data collection and charting tools. Periodic reminders of their commitment to the Safe Critical Care Initiative and access to web site containing all of the educational seminars, clinical tools, and quality improvement tools. ICUs in this group were on their own to initiate and implement a local hospital quality improvement initiative preventing CLABSI and VAP.</description>
    <arm_group_label>Tool Kit Group</arm_group_label>
    <other_name>Quality Improvement</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medical centers with at least one adult or pediatric ICU.

          -  Medical centers within the Hospital Corporation of America (HCA) were eligible for
             enrollment.

        Exclusion Criteria:

          -  Nonresponse to invitation to participate in our Safe Critical Care Initiative.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theodore Speroff, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>HCA Hospital Corporation of America</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Talbot TR, Tejedor SC, Greevy RA, Burgess H, Williams MV, Deshpande JK, McFadden P, Weinger MB, Englebright J, Dittus RS, Speroff T. Survey of infection control programs in a large national healthcare system. Infect Control Hosp Epidemiol. 2007 Dec;28(12):1401-3. Epub 2007 Nov 1.</citation>
    <PMID>17994522</PMID>
  </results_reference>
  <results_reference>
    <citation>Wall RJ, Ely EW, Talbot TR, Weinger MB, Williams MV, Reischel J, Burgess LH, Englebright J, Dittus RS, Speroff T, Deshpande JK. Evidence-based algorithms for diagnosing and treating ventilator-associated pneumonia. J Hosp Med. 2008 Sep;3(5):409-22. doi: 10.1002/jhm.317. Review.</citation>
    <PMID>18951395</PMID>
  </results_reference>
  <results_reference>
    <citation>Patel RP, Gambrell M, Speroff T, Scott TA, Pun BT, Okahashi J, Strength C, Pandharipande P, Girard TD, Burgess H, Dittus RS, Bernard GR, Ely EW. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med. 2009 Mar;37(3):825-32. doi: 10.1097/CCM.0b013e31819b8608.</citation>
    <PMID>19237884</PMID>
  </results_reference>
  <results_reference>
    <citation>France DJ, Greevy RA Jr, Liu X, Burgess H, Dittus RS, Weinger MB, Speroff T. Measuring and comparing safety climate in intensive care units. Med Care. 2010 Mar;48(3):279-84. doi: 10.1097/MLR.0b013e3181c162d6.</citation>
    <PMID>20125046</PMID>
  </results_reference>
  <results_reference>
    <citation>Speroff T, Ely EW, Greevy R, Weinger MB, Talbot TR, Wall RJ, Deshpande JK, France DJ, Nwosu S, Burgess H, Englebright J, Williams MV, Dittus RS. Quality improvement projects targeting health care-associated infections: comparing Virtual Collaborative and Toolkit approaches. J Hosp Med. 2011 May;6(5):271-8. doi: 10.1002/jhm.873. Epub 2011 Feb 10.</citation>
    <PMID>21312329</PMID>
  </results_reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2009</study_first_submitted>
  <study_first_submitted_qc>September 11, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2009</study_first_posted>
  <results_first_submitted>June 16, 2013</results_first_submitted>
  <results_first_submitted_qc>December 8, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 12, 2016</results_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>Theodore Speroff</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Quality Improvement</keyword>
  <keyword>Critical Care</keyword>
  <keyword>Collaboratives</keyword>
  <keyword>Patient Safety</keyword>
  <keyword>Tool Kit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Leaders of all medical centers with at least 1 adult or pediatric ICU received an invitation to participate in a Quality Improvement initiative. Hospitals willing to participate were matched on geographic location and ICU volume and then randomized into either the Collaborative or Tool Kit Group in December 2005.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Collaborative Group</title>
          <description>One group of hospitals is randomly allocated to the Collaborative Group</description>
        </group>
        <group group_id="P2">
          <title>Tool Kit Group</title>
          <description>One group of hospitals is allocated randomly to the Tool Kit Group</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="29">1 hospital was sold, yielding 29 hospitals in the Tool Kit Group</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Unit of analysis is Hospital and ICU</population>
      <group_list>
        <group group_id="B1">
          <title>Collaborative Group</title>
          <description>One group of hospitals is randomly allocated to the Collaborative Group</description>
        </group>
        <group group_id="B2">
          <title>Tool Kit Group</title>
          <description>One group of hospitals is allocated randomly to the Tool Kit Group</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <description>Participants reporting whether ICU is pediatric (Age &lt; 18 years) or adult (Age &gt; 18 years) on baseline survey</description>
          <units>Hospitals</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Pediatric ICU (Age &lt; 18 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adult ICU (Age &gt;= 18 years)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender, Customized</title>
          <description>baseline survey, percent of ICU patient volume that is female</description>
          <units>Percentage of ICU female patient volume</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Average % Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.7" spread="5.7"/>
                    <measurement group_id="B2" value="50.3" spread="7.7"/>
                    <measurement group_id="B3" value="50" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ICU annual patient volume</title>
          <description>Patient volume was collected by a baseline survey of each participating hospital</description>
          <units>ICU patients/year</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="568" lower_limit="294" upper_limit="904"/>
                    <measurement group_id="B2" value="578" lower_limit="244" upper_limit="1077"/>
                    <measurement group_id="B3" value="570" lower_limit="250" upper_limit="950"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ICU mortality rate</title>
          <description>Annual ICU mortality rate provided by baseline survey among participating hospitals</description>
          <units>ICU mortality rate/year</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.7" spread="3.1"/>
                    <measurement group_id="B2" value="7.1" spread="3.6"/>
                    <measurement group_id="B3" value="6" spread="3.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medicare case-mix weight</title>
          <description>Average Medicare Case-Mix Index for annual ICU patient volume collected by baseline survey of participating hospitals. Patients are assigned to Medicare Severity-Diagnosis Related Groups (MS-DRG) based on principal and secondary diagnoses, age, procedures performed, co-morbidity, complications, discharge status, and gender. Each MS-DRG has a numeric weight that indicates the amount of resources required to treat patients in the group. The index, the average of the MS-DRG weights, measures the relative cost needed to treat the case-mix of patients in a hospital during the calendar year.</description>
          <units>Medicare Case-Mix Index/year</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1221" spread="1007"/>
                    <measurement group_id="B2" value="1295" spread="1110"/>
                    <measurement group_id="B3" value="1250" spread="1000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>CLABSI and VAP Rates</title>
        <description>Central line associated bloodstream infections(CLABSI) and ventilator associated pneumonias (VAP) using Centers for Disease Control and Prevention definitions as number of events per 1,000 device days, data collection and surveillance methods.</description>
        <time_frame>18 Months: 3-month baseline and quarterly post-intervention periods</time_frame>
        <population>A cluster randomized trial randomly assigned hospitals to either the Collaborative or Tool Kit groups, stratified by region within the United States and ICU volume. Implementation and analysis was at the level of the ICU. One of the 30 hospital in the Tool Kit Group was sold, leaving 29 hospitals. Analysis was conducted per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Collaborative Group</title>
            <description>Hospitals randomly allocated to the Virtual Collaborative involving teleconferences and Tool Kit</description>
          </group>
          <group group_id="O2">
            <title>Tool Kit Group</title>
            <description>Hospitals allocated randomly to the Tool Kit containing evidence-based guidelines and aides for conducting quality improvement</description>
          </group>
        </group_list>
        <measure>
          <title>CLABSI and VAP Rates</title>
          <description>Central line associated bloodstream infections(CLABSI) and ventilator associated pneumonias (VAP) using Centers for Disease Control and Prevention definitions as number of events per 1,000 device days, data collection and surveillance methods.</description>
          <population>A cluster randomized trial randomly assigned hospitals to either the Collaborative or Tool Kit groups, stratified by region within the United States and ICU volume. Implementation and analysis was at the level of the ICU. One of the 30 hospital in the Tool Kit Group was sold, leaving 29 hospitals. Analysis was conducted per protocol.</population>
          <units>events/1000 device days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline CLABSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.84" lower_limit="0" upper_limit="3.83"/>
                    <measurement group_id="O2" value="2.42" lower_limit="0.65" upper_limit="6.80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month CLABSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.24" lower_limit="0.54" upper_limit="4.69"/>
                    <measurement group_id="O2" value="2.47" lower_limit="1.48" upper_limit="5.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month CLABSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.28" lower_limit="0.0" upper_limit="3.73"/>
                    <measurement group_id="O2" value="2.54" lower_limit="0.0" upper_limit="4.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 month CLABSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" lower_limit="0.0" upper_limit="2.71"/>
                    <measurement group_id="O2" value="1.17" lower_limit="0.0" upper_limit="3.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 Month CLABSI</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.76" lower_limit="0.0" upper_limit="4.67"/>
                    <measurement group_id="O2" value="1.16" lower_limit="0.0" upper_limit="5.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Baseline VAP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.14" lower_limit="0.0" upper_limit="6.09"/>
                    <measurement group_id="O2" value="3.49" lower_limit="0.0" upper_limit="7.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 Month VAP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.01" lower_limit="0.0" upper_limit="9.11"/>
                    <measurement group_id="O2" value="3.32" lower_limit="0.0" upper_limit="8.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 Month VAP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.72" lower_limit="0.0" upper_limit="7.09"/>
                    <measurement group_id="O2" value="4.61" lower_limit="0.0" upper_limit="9.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12 Month VAP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.67" lower_limit="0.0" upper_limit="4.47"/>
                    <measurement group_id="O2" value="2.66" lower_limit="0.0" upper_limit="4.82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 Month VAP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.93" lower_limit="0.0" upper_limit="7.63"/>
                    <measurement group_id="O2" value="2.06" lower_limit="0.0" upper_limit="6.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Infection rates were analyzed using hierarchical negative binomial regression models to model infection rate changes over time and account for clustering of ICUs within hospitals and adjusting for baseline covariates. Power was calculated a priori with a 1-tailed alpha of 0.05 and group size of 30; a 50% decrease in infection rates in the Collaborative group and 15% for the Tool Kit group, yielding power ranging from 82% to 91% for testing group differences.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;.05</p_value>
            <p_value_desc>p-value and confidence intervals</p_value_desc>
            <method>Regression, Linear</method>
            <param_type>infection rates per device days</param_type>
            <param_value>2.00</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>.05</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.0</ci_lower_limit>
            <ci_upper_limit>3.0</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Access of Tools and Use of Quality Improvement Strategies</title>
        <description>Follow-up survey of ICU nurse and quality managers for all participating medical centers from Jan 2008 through April 2008 included questions about the implementation of process interventions: Access and use of clinical guidelines tools, access and use of quality improvement tools, and types of quality improvement implementation strategies.</description>
        <time_frame>18 months</time_frame>
        <population>per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Collaborative Group</title>
            <description>Hospitals randomly allocated to the Virtual Collaborative involving teleconferences and Tool Kit</description>
          </group>
          <group group_id="O2">
            <title>Tool Kit Group</title>
            <description>Hospitals allocated randomly to only a Tool Kit of clinical guidelines and aides for quality improvement</description>
          </group>
        </group_list>
        <measure>
          <title>Access of Tools and Use of Quality Improvement Strategies</title>
          <description>Follow-up survey of ICU nurse and quality managers for all participating medical centers from Jan 2008 through April 2008 included questions about the implementation of process interventions: Access and use of clinical guidelines tools, access and use of quality improvement tools, and types of quality improvement implementation strategies.</description>
          <population>per protocol</population>
          <units>Percentage of ICUs</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="19"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Clinical Tool Use</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Data Tools</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="56"/>
                    <measurement group_id="O2" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Strategies</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                    <measurement group_id="O2" value="54"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>It was hypothesized that the Collaborative group would engage in more processes and tools than the Tool Kit group. Power was based on infection rates.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;05</p_value>
            <method>Chi-squared</method>
            <param_type>percentages</param_type>
            <param_value>10</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <estimate_desc>Power calculation used alpha = .05 and group size = 30.The estimated effect was a 50% decrease in infection rates for the Collaborative Group and from 10% to 15% decrease in the Tool Kit group.Power ranged from 82%-91% for testing group differences.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>No other adverse event data were collected other than the primary study outcomes</time_frame>
      <desc>0 hospital (ICU) participants were at risk as no other adverse events were collected or assessed other than the primary study outcomes.</desc>
      <group_list>
        <group group_id="E1">
          <title>Collaborative Group</title>
          <description>Hospitals allocated randomly to the Collaborative Quality Improvement intervention with teleconferences and Tool Kit</description>
        </group>
        <group group_id="E2">
          <title>Tool Kit Group</title>
          <description>Hospitals allocated randomly to the Tool Kit containing evidence-based guidelines and aides for quality improvement</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Each participant tailored their interventions; we were not able to test the components of CQI. Data were dependent on self-reports. Our collaborative was virtual and does not address benefits from face-to-face networking of large scale projects.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Theodore Speroff</name_or_title>
      <organization>Vanderbilt University School of Medicine</organization>
      <phone>615-636-9476</phone>
      <email>ted.speroff@vanderbilt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

